MILESTONE SCIENTIFIC INC.
Last · NYSE American$0.348-0.002 (-0.57%)stale · yahoo · 61h ago
Market cap$31.53M90.6M sh
P/E · TTM-8.8fwd -9.9 · eps -0.04 · loss
Beta1.13vs S&P 500
Div yield0.00%annual · TTM
52w range
$0.22$0.58
Volume138.6Ksession
| Revenue | $5.0M |
|---|---|
| Operating income | $-1.9M |
| Net income | $-1.9M |
| Free cash flow | $-504,056 |
| Operating margin | -37.8% |
| Net margin | -38.0% |
| Return on equity | -54.7% |
| Period | 2026 |
Loading chart…
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.01
Est. revenue
2.4M
Press & signals
- GlobeNewswire
Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor
- GlobeNewswire
Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors
- GlobeNewswire
Milestone Scientific Reports Financial Results for Second Quarter 2026
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags